IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment (2015)
- Authors:
- USP affiliated authors: TIEZZI, DANIEL GUIMARÃES - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; SILVA, JOÃO SANTANA DA - FMRP
- Unidade: FMRP
- DOI: 10.1158/0008-5472.CAN-15-0054
- Subjects: NEOPLASIAS MAMÁRIAS; CARCINOMA DE DUCTOS INFILTRANTE; CITOCINAS; SOBREVIVÊNCIA LIVRE DE DOENÇA; REGULAÇÃO GÊNICA; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Research
- ISSN: 0008-5472
- Volume/Número/Paginação/Ano: v. 75, n. 8, p. 3788-3799, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
BENEVIDES, Luciana et al. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Research, v. 75, n. 8, p. 3788-3799, 2015Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.CAN-15-0054. Acesso em: 27 dez. 2025. -
APA
Benevides, L., Fonseca, D. M. da, Donate, P. B., Tiezzi, D. G., Carvalho, D. D. de, Andrade, J. M. de, et al. (2015). IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Research, 75( 8), 3788-3799. doi:10.1158/0008-5472.CAN-15-0054 -
NLM
Benevides L, Fonseca DM da, Donate PB, Tiezzi DG, Carvalho DD de, Andrade JM de, Martins GA, Silva JS da. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment [Internet]. Cancer Research. 2015 ; 75( 8): 3788-3799.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1158/0008-5472.CAN-15-0054 -
Vancouver
Benevides L, Fonseca DM da, Donate PB, Tiezzi DG, Carvalho DD de, Andrade JM de, Martins GA, Silva JS da. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment [Internet]. Cancer Research. 2015 ; 75( 8): 3788-3799.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1158/0008-5472.CAN-15-0054 - HIF-1'alfa' and locally advanced breast cancer [Carta]
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Cancer stem cells and lymph node metastasis in early stage breast cancer
- VEGF and HIF-1 alpha plasma level as prognostic factor in locally advanced breast cancer submitted to neoadjuvant chemotherapy
- Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor
Informações sobre o DOI: 10.1158/0008-5472.CAN-15-0054 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
